nitroglycerin has been researched along with paclitaxel in 12 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 5 (41.67) | 29.6817 |
| 2010's | 7 (58.33) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| González-Díaz, H; Orallo, F; Quezada, E; Santana, L; Uriarte, E; Viña, D; Yáñez, M | 1 |
| Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
| Kim, JW; Oh, DJ; Park, CG; Seo, HS | 1 |
| Cocchia, R; Cook, S; Hess, OM; Meier, B; Räber, L; Togni, M; Wenaweser, P; Windecker, S | 1 |
| Farhan, S; Glogar, D; Gyöngyösi, M; Hemetsberger, R; Huber, K; Kaider, A; Khorsand, A; Matiasek, J; Pavo, N; Petneházy, O; Petrási, Z; Strehblow, C | 1 |
| Cinçin, A; Değertekin, M; Gemici, G; Oktay, A | 1 |
| Brants, I; Brott, BC; Chen, JP; Chronos, N; Hou, D; King, SB; Li, J; Nakamura, T; Panchal, D | 1 |
| Chibana, H; Fukumoto, Y; Ikeno, F; Itaya, N; Mitsutake, Y; Nakayoshi, T; Sasaki, K; Sasaki, M; Ueno, T; Yokoyama, S | 1 |
| Aerts, JG; Bahce, I; Biesma, B; Burgers, JA; Dingemans, AM; Groen, HJ; Herder, GJ; Smit, EF; Stigt, JA; van den Borne, BE; van der Noort, V; Vincent, A | 1 |
| Boellaard, R; de Jong, EE; Dingemans, AC; Groen, HJ; Hoekstra, OS; Lambin, P; Leijenaar, RT; Smit, EF; Troost, EG; van der Noort, V; van Elmpt, W | 1 |
| de Jong, EEC; Degens, JHRJ; Deist, TM; Dingemans, AC; Jochems, A; Lambin, P; Leijenaar, RTH; Sanders, KJC; Schols, AMWJ; van Elmpt, W; van Timmeren, JE | 1 |
1 review(s) available for nitroglycerin and paclitaxel
| Article | Year |
|---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
3 trial(s) available for nitroglycerin and paclitaxel
| Article | Year |
|---|---|
A randomized phase II study comparing paclitaxel-carboplatin-bevacizumab with or without nitroglycerin patches in patients with stage IV nonsquamous nonsmall-cell lung cancer: NVALT12 (NCT01171170)†.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Bevacizumab; Carboplatin; Carcinoma, Non-Small-Cell Lung; Female; Humans; Hypoxia-Inducible Factor 1; Lung Neoplasms; Male; Middle Aged; Neoplasm Staging; Nitroglycerin; Paclitaxel | 2015 |
[18F]FDG PET/CT-based response assessment of stage IV non-small cell lung cancer treated with paclitaxel-carboplatin-bevacizumab with or without nitroglycerin patches.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bevacizumab; Carboplatin; Carcinoma, Non-Small-Cell Lung; Feasibility Studies; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Male; Middle Aged; Neoplasm Staging; Netherlands; Nitroglycerin; Paclitaxel; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Survival Rate; Treatment Outcome; Vasodilator Agents | 2017 |
Can radiomics help to predict skeletal muscle response to chemotherapy in stage IV non-small cell lung cancer?
Topics: Antineoplastic Combined Chemotherapy Protocols; Area Under Curve; Bevacizumab; Carboplatin; Carcinoma, Non-Small-Cell Lung; Cohort Studies; Cross-Sectional Studies; Female; Follow-Up Studies; Humans; Lung Neoplasms; Male; Middle Aged; Muscle, Skeletal; Neoplasm Staging; Nitroglycerin; Paclitaxel; Survival Rate; Tomography, X-Ray Computed | 2019 |
8 other study(ies) available for nitroglycerin and paclitaxel
| Article | Year |
|---|---|
Quantitative structure-activity relationship and complex network approach to monoamine oxidase A and B inhibitors.
Topics: Computational Biology; Drug Design; Humans; Isoenzymes; Molecular Structure; Monoamine Oxidase; Monoamine Oxidase Inhibitors; Quantitative Structure-Activity Relationship | 2008 |
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Delayed severe multivessel spasm and aborted sudden death after Taxus stent implantation.
Topics: Blood Vessel Prosthesis; Coronary Stenosis; Coronary Vasospasm; Death, Sudden, Cardiac; Delayed-Action Preparations; Drug Implants; Female; Humans; Middle Aged; Nitroglycerin; Paclitaxel; Risk Factors; Stents; Vasodilator Agents | 2005 |
Local vascular dysfunction after coronary paclitaxel-eluting stent implantation.
Topics: Administration, Sublingual; Antineoplastic Agents, Phytogenic; Blood Vessel Prosthesis Implantation; Coated Materials, Biocompatible; Coronary Angiography; Coronary Restenosis; Coronary Stenosis; Coronary Vasospasm; Diagnosis, Differential; Electrocardiography; Exercise Test; Female; Follow-Up Studies; Humans; Male; Middle Aged; Nitroglycerin; Paclitaxel; Postoperative Complications; Stents; Time Factors; Treatment Outcome; Vasoconstriction; Vasodilator Agents | 2007 |
Implantation of paclitaxel-eluting stent impairs the vascular compliance of arteries in porcine coronary stenting model.
Topics: Animals; Antineoplastic Agents, Phytogenic; Coronary Restenosis; Coronary Stenosis; Coronary Vessels; Disease Models, Animal; Drug-Eluting Stents; Female; Inflammation; Male; Metals; Nitroglycerin; Paclitaxel; Swine; Vasodilation | 2009 |
Paclitaxel-induced ST-segment elevations.
Topics: Acute Coronary Syndrome; Administration, Sublingual; Angina Pectoris; Angioplasty, Balloon, Coronary; Antineoplastic Agents, Phytogenic; Biomarkers; Carcinoma; Coronary Angiography; Coronary Vasospasm; Creatine Kinase, MB Form; Electrocardiography; Female; Humans; Infusions, Intravenous; Middle Aged; Nitroglycerin; Ovarian Neoplasms; Paclitaxel; Stents; Treatment Outcome; Troponin T; Vasodilator Agents | 2009 |
Vasomotor function after paclitaxel-coated balloon post-dilation in porcine coronary stent model.
Topics: Acetylcholine; Angioplasty, Balloon, Coronary; Animals; Cardiovascular Agents; Coated Materials, Biocompatible; Coronary Angiography; Coronary Vessels; Dose-Response Relationship, Drug; Endothelium, Vascular; Equipment Design; Linear Models; Models, Animal; Nitroglycerin; Paclitaxel; Swine; Time Factors; Vasodilation; Vasodilator Agents | 2011 |
Serial changes of coronary endothelial function and arterial healing after paclitaxel-eluting stent implantation.
Topics: Acetylcholine; Aged; Angina, Stable; Angioscopy; Coronary Angiography; Coronary Artery Disease; Coronary Stenosis; Coronary Vessels; Drug-Eluting Stents; Endothelium, Vascular; Female; Follow-Up Studies; Humans; Male; Middle Aged; Nitroglycerin; Paclitaxel; Percutaneous Coronary Intervention; Tunica Intima; Vasodilator Agents | 2016 |